Cliff Asness’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.96M Buy
1,497,673
+435,833
+41% +$1.2M ﹤0.01% 1886
2026
Q1
$1.42M Buy
+1,061,840
New +$2.12M ﹤0.01% 2581
2025
Q4
Sell
-129,868
Closed -$871K 3644
2025
Q3
$871K Sell
129,868
-33,994
-21% -$222K ﹤0.01% 2517
2025
Q2
$964K Buy
163,862
+105,339
+180% +$686K ﹤0.01% 2225
2025
Q1
$491K Buy
+58,523
New +$526K ﹤0.01% 2437
2023
Q3
Sell
-9,566
Closed -$245K 2385
2023
Q2
$245K Buy
+9,566
New +$247K ﹤0.01% 2019

Other funds holding TMCI

Cliff Asness's TMCI Position: Q2 2026 in Review

Cliff Asness increased its Treace Medical Concepts (TMCI) stake by 41% in Q2 2026, buying an estimated $1.2M and bringing the position to 1,497,673 shares worth $5.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1886.

Cliff Asness first reported a position in TMCI in Q2 2023 and has held it in 6 quarters since. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Cliff Asness held 1,497,673 shares of Treace Medical Concepts worth $5.96M as of Q2 2026.
  • Cliff Asness bought 435,833 Treace Medical Concepts shares in Q2 2026, an estimated $1.2M.
  • Treace Medical Concepts made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1886 holding.
  • Cliff Asness first reported a position in Treace Medical Concepts in Q2 2023 and has held it in 6 quarters since.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.